Encompass Health Corporation (NYSE:EHC) Receives Consensus Rating of “Buy” from Analysts

Shares of Encompass Health Corporation (NYSE:EHC) have been assigned an average recommendation of “Buy” from the eleven analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $142.8571.

A number of research analysts have recently commented on the stock. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Zacks Research downgraded Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Finally, Barclays increased their target price on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th.

Institutional Trading of Encompass Health

Institutional investors have recently modified their holdings of the company. Citizens National Bank Trust Department acquired a new position in Encompass Health during the third quarter valued at approximately $26,000. First Horizon Corp purchased a new position in shares of Encompass Health in the 3rd quarter valued at $34,000. WPG Advisers LLC lifted its holdings in shares of Encompass Health by 73.3% during the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after acquiring an additional 137 shares in the last quarter. Westside Investment Management Inc. boosted its position in Encompass Health by 56.7% during the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after purchasing an additional 101 shares during the period. Finally, Flagship Harbor Advisors LLC acquired a new stake in Encompass Health in the 4th quarter valued at $37,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

EHC stock opened at $94.28 on Wednesday. The stock has a market capitalization of $9.49 billion, a price-to-earnings ratio of 17.82, a price-to-earnings-growth ratio of 1.51 and a beta of 0.73. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76. Encompass Health has a 52-week low of $92.53 and a 52-week high of $127.99. The stock’s fifty day simple moving average is $105.22 and its 200-day simple moving average is $114.68.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.